Pharma news – 5 July 2020
Indian Government is reviewing the use of Remdesivir for Covid-19 following reports of liver damage The Union Health Ministry of India is currently reviewing the use of Remdesivir in the country. Multiple reports of liver damage in the Covid-19 patients treated with this drug have instigated this action. The side-effects of Remdesivir was one of […]